Bard Jamshidi Bone Marrow Needle Recall: Sterility Risk from Packaging
Bard recalls sterile bone marrow biopsy needles (product code DJ4011X) due to potential packaging pouch leaks causing sterility issues. Affected lots 0001303256 and 0001303257.
Lower-risk recall
Sterility compromised due to packaging pouches that may not be sealed properly
Contact the company
What happened, in plain English
Bard is recalling sterile bone marrow biopsy needles that may have packaging pouches not sealed properly, risking contamination. This could lead to infections if used without proper sterility. Read more at govinfonow.com/recall/65638-bard-jamshidi-bone-marrow-needle-recall-sterility-risk-from-packaging.
Source Summary by GovInfoNow · govinfonow.com/recall/65638-bard-jamshidi-bone-marrow-needle-recall-sterility-risk-from-packaging · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1689-2020
Cite this page
“Bard Jamshidi Bone Marrow Needle Recall: Sterility Risk from Packaging.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65638-bard-jamshidi-bone-marrow-needle-recall-sterility-risk-from-packaging. Based on FDA recall #Z-1689-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1689-2020%22&limit=1).
Why it’s dangerous
The packaging pouches may not seal properly, allowing contaminants to enter the sterile needle. This could cause infections during medical procedures if the needle is not properly sterilized.
Who’s affected
Healthcare professionals using the recalled needles for bone marrow biopsies. Patients receiving procedures with these needles are at risk of infection if sterility is compromised.
How to tell if you have this one
Check for product code DJ4011X on the packaging. Affected lots are 0001303256 and 0001303257. The needles are used for bone marrow biopsies with a Luer Lock Adapter.
- Brand
Bard- Category
Medical device
What to do — step by step
Check Product Code
Look for product code DJ4011X on the packaging to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 7 states.
FDA distribution: “Worldwide distribution - US Nationwide distribution in the states of FL, IL, NJ, NY, OH, TN, VA and countries of AUSTRALIA, INDIA, JAPAN, MALAYSIA, NEW ZEALAND, PHILIPPINES and SINGAPORE.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Florida, Illinois, New Jersey, New York, Ohio, Tennessee, Virginia.
Recall timeline
FDA terminated this recall 4.3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-1689-2020 (March 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1689-2020 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.